A new CDC study found frontline workers who received both doses of Pfizer-BioNTech or Moderna's vaccine lowered their risk of being infected by 90% - and one shot by 80%.
AstraZeneca says that its COVID-19 vaccine provided strong protection among all adults in a long-anticipated U.S. study
AstraZeneca says its COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease in final-stage U.S. testing, including in older adults
AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no increased risk of rare blood clots identified in Europe.
The THL research showed a sharp reduction in hospital care for elderly and at-risk vaccine recipients in Finland.
The company came under fire this week after U.S. government scientists accused it of releasing misleading data.
As the COVID-19 pandemic swept the globe countries — and states in the U.S. — are dealing with wave and wave of illness. As hot spots shift, these charts will be updated daily with new totals.
Coronavirus Update: AstraZeneca vaccine trial data under scrutiny in U.S.
A US government agency has raised concerns that AstraZeneca may have included out-of-date drug data in information provided during US trials for its Covid-19 vaccine.
In a statement, AstraZeneca said its COVID-19 vaccine had a 79% efficacy rate at preventing symptomatic COVID and was 100% effective in stopping severe disease and hospitalization.
Strain is more effective than original COVID and the British variant at bypassing the shot, Israeli scientists find, in first-of-its-kind, real-world study
More than 15 million jabs given to elderly between December and end of March